Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-I

by Liu, Xiaoqi, Zhang, Zixuan, Aguirre, Tim, Shipton, Megan L., Fu, Lin, Du, Jimin, Furkert, David, Qi, Ji, Chin, Alfred C., Riley, Andrew M., Liu, Tong, Zhang, Xu, Potter, Barry V. L., Fiedler, Dorothea, Zhu, Yi, Fu, Chenglai
Published in Metabolism (2024)